ns 1619 has been researched along with Nerve Pain in 1 studies
NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, H | 1 |
| Xue, Q | 1 |
| Li, C | 1 |
| Wang, Q | 1 |
| Han, S | 1 |
| Zhou, Y | 1 |
| Yang, T | 1 |
| Xie, Y | 1 |
| Fu, H | 1 |
| Lu, C | 1 |
| Meng, F | 1 |
| Zhang, M | 1 |
| Zhang, Y | 1 |
| Wu, X | 1 |
| Wu, S | 1 |
| Zhuo, M | 1 |
| Xu, H | 1 |
1 other study available for ns 1619 and Nerve Pain
| Article | Year |
|---|---|
Upregulation of Beta4 subunit of BK
Topics: Animals; Anxiety; Behavior, Animal; Benzimidazoles; Excitatory Postsynaptic Potentials; Ganglia, Spi | 2020 |